The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss ... the ...

The proliferation of smoking-related diseases, including respiratory, cardiovascular, cancer, diabetes, dementia and ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...